Ioanna Gouni-Berthold, University of Cologne, Germany, considers key questions and potential inclusion criteria for future cardiovascular outcomes trials with novel agents that have shown significantly greater TG-lowering effects than current therapies.
Please login or create a FREE account to view this content
Educational Supporters of the 11th Closed Scientific Expert Meeting of the Editorial Board
Principal supporters:
Guest supporters:
